4'-methyl-4-mercaptobiphenyl | 200958-14-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4'-methyl-4-mercaptobiphenyl
• 英文别名: [1,1'-Biphenyl]-4-thiol, 4'-methyl-；4-(4-methylphenyl)benzenethiol
• CAS: 200958-14-1
• 化学式: C₁₃H₁₂S
• mdl: MFCD06201771
• 分子量: 200.304
• InChiKey: IOOGUXDWDUHGAV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.076
• 拓扑面积：
  1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (5,5,6,6,7,7,8,8,8-nonafluoro-1-iodooctan-3-yl)diphenylphosphine oxide 、 4'-methyl-4-mercaptobiphenyl 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 12.0h， 以87%的产率得到(5,5,6,6,7,7,8,8,8-nonafluoro-1-(p-tolylthio)octan-3-yl)diphenylphosphine oxide
  参考文献：
  名称：

  自由基介导的烷氧基膦重排对未活化烯烃的区域选择性氟烷基磷酸化**

  摘要：

  未活化烯烃的区域选择性自由基氟烷基磷酸化是通过 (双) 高烯丙醇、氯化膦和氟烷基碘化物在紧凑型荧光 (CFL) 照射下的一锅反应开发的。该协议采用一种新颖的烷氧基膦自由基重排，通过（双）高烯丙醇的脱羟基三官能化，在末端烯烃的内侧实现磷酰基的异常安装。

  DOI：

  10.1002/anie.202203398
• 作为产物：
  描述：

  4-溴苯硫酚 在 四(三苯基膦)钯 sodium hydroxide 、 potassium phosphate 、 sodium hydride 作用下， 以 四氢呋喃 、 乙二醇二甲醚 、 水 为溶剂， 反应 59.75h， 生成 4'-methyl-4-mercaptobiphenyl
  参考文献：
  名称：

  Protecting Groups for Thiols Suitable for Suzuki Conditions

  摘要：

  The thiol group is one of the few groups NOT tolerated by the Suzuki reaction. Therefore, a new protective group, the 2-methoxyisobutyryl group, was developed by tuning the electronic/steric properties of the acyl residue. Other thioesters, such as thioacetate, result in a more or less dominant side reaction, which to date has not been described: sulfur-assisted acylation of boronic acids. The reaction pathway for this new reaction is discussed.

  DOI：

  10.1021/ol0058902

文献信息

• Surface-Modified Carbon Felts:  Possible Supports for Combinatorial Chemistry
  作者：Estelle Coulon、Jean Pinson、Jean-Dominique Bourzat、Alain Commerçon、Jean-Pierre Pulicani

  DOI：10.1021/jo025880+

  日期：2002.11.1

  possible to prepare carbon-based analogues of the Merrifield resin by electrochemical reduction of diazonium salts or oxidation of aryl acetates on high specific surface area carbon felts. These modified felts can undergo further reactions: nucleophilic substitution, Suzuki reaction, and finally reductive electrochemical cleavage, taking advantage of the conductivity of the carbon felt. This provides

  通过在高比表面积碳毡上进行电化学还原重氮盐或氧化乙酸芳基酯，可以制备Merrifield树脂的碳基类似物。这些改性的毡可以进一步进行反应：利用碳毡的导电性，进行亲核取代，Suzuki反应，最后进行还原性电化学裂解。这提供了电化学在组合合成中的可能用途的简单示例。
• [EN] COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES<br/>[FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT DE MALADIES LIÉES À L'OXALATE
  申请人：OXALURX INC

  公开号：WO2019165159A1

  公开（公告）日：2019-08-29

  Disclosed herein are compounds and compositions for modulating glycolate oxidase, useful for treating oxalate-related diseases, such as hyperoxaluria, where modulating glycolate oxidase is expected to be therapeutic to a patent in need thereof. Methods of modulating glycolate oxidase activity in a human or animal subject is also provided.

  本文披露了用于调节甘醇酸氧化酶的化合物和组合物，用于治疗与草酸盐相关的疾病，如高草酸尿症，其中调节甘醇酸氧化酶预计对需要治疗的患者具有疗效。还提供了在人类或动物主体中调节甘醇酸氧化酶活性的方法。
• Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
  申请人：Arimilli N. Murty

  公开号：US20070010489A1

  公开（公告）日：2007-01-11

  Phosphonate substituted compounds with HIV protease inhibitory properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit 5 HIV protease activity and/or are useful therapeutically for the treatment of AIDS and other antiviral infections, as well as in assays for the detection of HIV protease.

  本发明揭示了具有HIV蛋白酶抑制剂性质的膦酸酯取代化合物，其具有作为治疗剂和其他工业用途的用途。该组合物抑制5型HIV蛋白酶活性和/或在治疗艾滋病和其他抗病毒感染方面具有治疗作用，以及在检测HIV蛋白酶方面的检测中有用。
• Compounds and methods for treating oxalate-related diseases
  申请人：OxaluRx, Inc.

  公开号：US11389456B2

  公开（公告）日：2022-07-19

  Disclosed herein are compounds and compositions for modulating glycolate oxidase, useful for treating oxalate-related diseases, such as hyperoxaluria, where modulating glycolate oxidase is expected to be therapeutic to a patent in need thereof. Methods of modulating glycolate oxidase activity in a human or animal subject is also provided.

  本文公开了用于调节乙醇酸氧化酶的化合物和组合物，可用于治疗草酸盐相关疾病，如高草酸尿症，其中调节乙醇酸氧化酶有望对有需要的专利起到治疗作用。还提供了调节人或动物体内乙醇酸氧化酶活性的方法。
• Crystal nucleating chip
  申请人：——

  公开号：US20030068252A1

  公开（公告）日：2003-04-10

  The Crystal Nucleating Chip is suitable for use as a high-throughput, low cost, disposable mono-layer array type device, specifically for simultaneously forming crystals of inorganic or organic solute under the inducement of an array of unique SAM's chemical functional head groups and determining their effects on crystal polymorphism and crystal habit of the solute in solutions. The array is a substrate divided into a pattern of pads that directly or indirectly support a number of test compounds each with a specific structure and functionality. A method of using the invention involves bringing the array into contact with a solution in order to promote potential crystallization of the solute. The method further allows for qualitatively determining polymorphism, i.e., crystal formation, and crystal habit of the specific test compounds, e.g. SAMs, through a variety of spectroscopic and microscopic techniques.

  晶体成核芯片适合用作一种高通量、低成本、一次性单层阵列型设备，专门用于在独特的 SAM 化学官能团阵列的诱导下同时形成无机或有机溶质的晶体，并确定它们对溶液中溶质的晶体多态性和晶体习性的影响。该阵列是一种基底，分为直接或间接支撑一些测试化合物的垫状图案，每种化合物都具有特定的结构和功能。使用本发明的方法包括将阵列与溶液接触，以促进溶质的潜在结晶。该方法还可通过各种光谱和显微技术定性确定特定测试化合物（如 SAM）的多态性（即晶体形成）和晶体习性。